Literature DB >> 9820830

Interleukin 1beta decreases prostacyclin synthase activity in rat mesangial cells via endogenous peroxynitrite formation.

M H Zou1, T Klein, J P Pasquet, V Ullrich.   

Abstract

We have reported that peroxynitrite (PON) selectively inactivated prostacyclin synthase (PGIS) by a mechanism of tyrosine nitration at the active site [Zou, Martin and Ullrich (1997) Biol. Chem. Hoppe-Seyler 378, 707-713]. We have now extended our studies on rat mesangial cells (RMC) and show that nitration can occur under the influence of cytokines. Pretreatment of RMC with interleukin 1beta (IL-1beta), which up-regulated cyclo-oxygenase 2 and inducible nitric oxide synthase (NOS-2), significantly attenuated the conversion of [14C]prostaglandin H2 (PGH2) into the stable prostacyclin (PGI2) metabolite 6-oxo-prostaglandin F1alpha (6-oxo-PGF1alpha). The presence of superoxide dismutase (SOD, 100 units/ml) or the NOS synthase inhibitor Nomega-monomethyl-l-arginine (100 microM) as well as cycloheximide (10 microM) plus actinomycin (10 microM) abolished IL-1beta-mediated down-regulation of 6-oxo-PGF1alpha from PGH2. At the same time, 6-oxo-PGF1alpha production from arachidonate (AA) increased at the expense of prostaglandin E2 (PGE2). Neither NO alone generated from different NO donors nor superoxide from xanthine/xanthine oxidase (1-100 m-units/ml) inhibited PGI2 synthesis, either from PGH2 or from AA. Bolus additions of chemically synthesized PON or the PON generator 3-morpholinosydnonimine N-ethylcarbamide (SIN-1) exhibited a potent inhibition of 6-oxo-PGF1alpha release from both PGH2 and AA. In addition, immunoprecipitation of nitrotyrosine-containing proteins from PON- and SIN-1-treated RMC yielded distinct nitrated PGIS bands but also from IL-1beta-pretreated cells alone, compared with a lack of nitrated PGIS in control cells. Taken together, our results strongly suggest that IL-1beta pretreatment of RMC via NOS-2 leads to the production of PON with the consequence of a partial nitration and inhibition of PGIS.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9820830      PMCID: PMC1219897          DOI: 10.1042/bj3360507

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  23 in total

Review 1.  The L-arginine-nitric oxide pathway.

Authors:  S Moncada; A Higgs
Journal:  N Engl J Med       Date:  1993-12-30       Impact factor: 91.245

Review 2.  Arachidonic acid metabolism.

Authors:  P Needleman; J Turk; B A Jakschik; A R Morrison; J B Lefkowith
Journal:  Annu Rev Biochem       Date:  1986       Impact factor: 23.643

3.  Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide.

Authors:  R Radi; J S Beckman; K M Bush; B A Freeman
Journal:  J Biol Chem       Date:  1991-03-05       Impact factor: 5.157

4.  The reaction of no with superoxide.

Authors:  R E Huie; S Padmaja
Journal:  Free Radic Res Commun       Date:  1993

Review 5.  Involvement of reactive oxygen species in kidney damage.

Authors:  L Baud; R Ardaillou
Journal:  Br Med Bull       Date:  1993-07       Impact factor: 4.291

6.  Cytokine-stimulated secretion of group II phospholipase A2 by rat mesangial cells. Its contribution to arachidonic acid release and prostaglandin synthesis by cultured rat glomerular cells.

Authors:  J Pfeilschifter; C Schalkwijk; V A Briner; H van den Bosch
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

7.  Kinetics of superoxide dismutase- and iron-catalyzed nitration of phenolics by peroxynitrite.

Authors:  J S Beckman; H Ischiropoulos; L Zhu; M van der Woerd; C Smith; J Chen; J Harrison; J C Martin; M Tsai
Journal:  Arch Biochem Biophys       Date:  1992-11-01       Impact factor: 4.013

8.  Stoichiometry and kinetics of the interaction of prostaglandin H synthase with anti-inflammatory agents.

Authors:  R J Kulmacz; W E Lands
Journal:  J Biol Chem       Date:  1985-10-15       Impact factor: 5.157

9.  Oxygen and oxidation promote the release of nitric oxide from sydnonimines.

Authors:  H Bohn; K Schönafinger
Journal:  J Cardiovasc Pharmacol       Date:  1989       Impact factor: 3.105

10.  Vasoconstrictor-evoked prostaglandin synthesis in cultured human mesangial cells.

Authors:  N Ardaillou; J Hagege; M P Nivez; R Ardaillou; D Schlondorff
Journal:  Am J Physiol       Date:  1985-02
View more
  12 in total

1.  Biomechanical Forces and Oxidative Stress: Implications for Pulmonary Vascular Disease.

Authors:  Evgeny A Zemskov; Qing Lu; Wojciech Ornatowski; Christina N Klinger; Ankit A Desai; Emin Maltepe; Jason X-J Yuan; Ting Wang; Jeffrey R Fineman; Stephen M Black
Journal:  Antioxid Redox Signal       Date:  2019-03-19       Impact factor: 8.401

2.  Tyrosine nitration of prostacyclin synthase is associated with enhanced retinal cell apoptosis in diabetes.

Authors:  Ming-Hui Zou; Hongliang Li; Chaoyong He; Mingkai Lin; Timothy J Lyons; Zhonglin Xie
Journal:  Am J Pathol       Date:  2011-10-18       Impact factor: 4.307

Review 3.  Molecular insights and therapeutic targets for diabetic endothelial dysfunction.

Authors:  Jian Xu; Ming-Hui Zou
Journal:  Circulation       Date:  2009-09-29       Impact factor: 29.690

4.  Enhanced tyrosine nitration of prostacyclin synthase is associated with increased inflammation in atherosclerotic carotid arteries from type 2 diabetic patients.

Authors:  Chaoyong He; Hyoung Chul Choi; Zhonglin Xie
Journal:  Am J Pathol       Date:  2010-03-26       Impact factor: 4.307

5.  Impaired response to interferon-gamma in activated macrophages due to tyrosine nitration of STAT1 by endogenous nitric oxide.

Authors:  M Llovera; J D Pearson; C Moreno; V Riveros-Moreno
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

6.  Nitration of succinyl-CoA:3-oxoacid CoA-transferase in rats after endotoxin administration.

Authors:  S Marcondes; I V Turko; F Murad
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

7.  Regulation of cytochrome P450 enzyme activity and expression by nitric oxide in the context of inflammatory disease.

Authors:  Edward T Morgan; Cene Skubic; Choon-Myung Lee; Kaja Blagotinšek Cokan; Damjana Rozman
Journal:  Drug Metab Rev       Date:  2020-09-08       Impact factor: 4.518

8.  Prostaglandin endoperoxide-dependent vasospasm in bovine coronary arteries after nitration of prostacyclin synthase.

Authors:  M Zou; M Jendral; V Ullrich
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

9.  Hypoxia-reoxygenation triggers coronary vasospasm in isolated bovine coronary arteries via tyrosine nitration of prostacyclin synthase.

Authors:  M H Zou; M Bachschmid
Journal:  J Exp Med       Date:  1999-07-05       Impact factor: 14.307

10.  Hypoxia upregulates PGI-synthase and increases PGI₂ release in human vascular cells exposed to inflammatory stimuli.

Authors:  Mercedes Camacho; Cristina Rodríguez; Anna Guadall; Sonia Alcolea; Mar Orriols; José-Román Escudero; José Martínez-González; Luis Vila
Journal:  J Lipid Res       Date:  2011-02-04       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.